CN104000871A - Drug for treating myocardial ischemia - Google Patents
Drug for treating myocardial ischemia Download PDFInfo
- Publication number
- CN104000871A CN104000871A CN201410276796.3A CN201410276796A CN104000871A CN 104000871 A CN104000871 A CN 104000871A CN 201410276796 A CN201410276796 A CN 201410276796A CN 104000871 A CN104000871 A CN 104000871A
- Authority
- CN
- China
- Prior art keywords
- myocardial ischemia
- parts
- drug
- medicine
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating myocardial ischemia. The drug is composed of following raw materials, by weight, 3-5 parts of panax notoginseng, 2-4 parts of andrographis paniculata, 3-5 parts of rhodiola rosea, 3-5 parts of folium ginkgo, and 3-5 parts of the root of red-rooted salvia. The drug is a pure Chinese material medical preparation, has no toxic and side effects, and is obvious in myocardial ischemia treatment effect.
Description
Technical field
The invention belongs to biomedicine field, be specifically related to a kind of medicine that is used for the treatment of myocardial ischemia.
Background technology
Myocardial ischemia refers to that the hemoperfusion of heart reduces, and causes the oxygen supply of heart to reduce, and energy metabolism of myocardial is undesired, can not support a kind of pathological state of the normal work of heart.The traditional Chinese medical science is referred to as " obstruction of qi in the chest and cardialgia ", " precordial pain with cold limbs ".Myocardial ischemia is clinical taking uncomfortable in chest, precordialgia as principal character.
The fundamental cause that myocardial ischemia occurs is that the oxygen delivery capacity of coronary flow is not enough to meet the demand of cardiac muscle to oxygen, and myocardial ischemia metabolite lactic acid, histamine and K+ accumulate, and stimulate sympathetic nerve to import maincenter into.Can be divided into again the angina pectoris of Secondary cases arteriosclerotic heart disease and the constitutional angina pectoris that coronary spasm, coronary artery thrombus cause by the mechanism of its morbidity.
Cause the cause of disease, the pathological process complexity of myocardial ischemia, at present to its treatment taking conservative medication as main.The key of the Drug therapy of myocardial ischemia is to make the supply of oxygen and consumption again reach balance, and its treatment means mainly can be divided into two classes, and one is to reduce myocardial oxygen consumption, and another kind is to improve coronary flow.At present clinically the medicaments for resisting myocardial ischemia of application have multiple, conventional nitrate esters, beta-blocker and the myocardial metabolism medicine etc. of comprising.
In recent years, China has carried out extensive and deep research to the Chinese herbal medicine resisting myocardial ischemia, excavate and improved motherland's Chinese medicine and pharmacy, as the Radix Salviae Miltiorrhizae from drug for invigorating blood circulation and eliminating stasis, Radix Notoginseng, Rhizoma Chuanxiong, Folium Ginkgo, Radix Ilicis Pubescentis, the Radix Puerariae of excavating from diaphoretic medicine, the Radix Ginseng of excavating from tonic, the Ilex purpurea Hassk.[I.chinensis Sims of excavating from heat and toxic materials clearing away medicine etc., show certain function of resisting myocardial ischemia through preliminary study.
Summary of the invention
The problem of comprehensive state of the art and existence, the object of the present invention is to provide a kind of medicine that is used for the treatment of myocardial ischemia, and the present invention is pure Chinese medicinal preparation, without any side effects, treatment myocardial ischemia successful.
For achieving the above object, the present invention is made up of the raw material of following mass ratio: Radix Notoginseng 3-5 part, Herba Andrographis 2-4 part, Radix Rhodiolae 3-5 part, Folium Ginkgo 3-5 part, Radix Salviae Miltiorrhizae 3-5 part.
The medicine that is used for the treatment of myocardial ischemia of the present invention, can select decoction dosage form, and its preparation method decocts for adding 5-10 times of water, takes night and morning.
The present invention is basic upper mentioned component, also can add suitable pharmaceutic adjuvant, is prepared into other peroral dosage forms, as granule, tablet, capsule, oral liquid etc. with conventional method of Chinese medicinal.
Detailed description of the invention
The medicine that embodiment 1. the present invention are used for the treatment of myocardial ischemia is made up of the raw material of following mass ratio: 5 parts of Radix Notoginseng, 2 parts of Herba Andrographis, 3 parts of Radix Rhodiolaes, 3 parts of Folium Ginkgos, 5 parts of Radix Salviae Miltiorrhizaes, and add 5 times of decoctings and boil, sooner or later respectively take 1 time.
The medicine that embodiment 2. the present invention are used for the treatment of myocardial ischemia is made up of the raw material of following mass ratio: 3 parts of Radix Notoginseng, 4 parts of Herba Andrographis, 5 parts of Radix Rhodiolaes, 5 parts of Folium Ginkgos, 3 parts of Radix Salviae Miltiorrhizaes, and add 9 times of decoctings and boil, sooner or later respectively take 1 time.
Embodiment 3. model cases: Wang, 61 years old, suffer from myocardial ischemia more than 3 years, usually uncomfortable in chest, cardiopalmus, breathe hard, take this product 1 week afterwards symptom be clearly better.
Claims (2)
1. be used for the treatment of the medicine of myocardial ischemia, formed by the raw material of following mass ratio: Radix Notoginseng 3-5 part, Herba Andrographis 2-4 part, Radix Rhodiolae 3-5 part, Folium Ginkgo 3-5 part, Radix Salviae Miltiorrhizae 3-5 part.
2. the medicine that is used for the treatment of myocardial ischemia according to claim 1, is characterized in that: described form of administration is peroral dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410276796.3A CN104000871A (en) | 2014-06-19 | 2014-06-19 | Drug for treating myocardial ischemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410276796.3A CN104000871A (en) | 2014-06-19 | 2014-06-19 | Drug for treating myocardial ischemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104000871A true CN104000871A (en) | 2014-08-27 |
Family
ID=51361960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410276796.3A Pending CN104000871A (en) | 2014-06-19 | 2014-06-19 | Drug for treating myocardial ischemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104000871A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055513A (en) * | 2015-07-22 | 2015-11-18 | 中国中医科学院中药研究所 | Effect of Shenlian extract in preventing and treating myocardial ischemic diseases and haze caused myocardial ischemic diseases |
| CN113559208A (en) * | 2021-08-27 | 2021-10-29 | 浙江天真健康科技有限公司 | A Chinese medicinal composition for protecting cardiovascular and cerebrovascular diseases, and its preparation method |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101524421A (en) * | 2008-12-31 | 2009-09-09 | 江西本草天工科技有限责任公司 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
-
2014
- 2014-06-19 CN CN201410276796.3A patent/CN104000871A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101524421A (en) * | 2008-12-31 | 2009-09-09 | 江西本草天工科技有限责任公司 | Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases |
Non-Patent Citations (2)
| Title |
|---|
| 吴基良等: ""穿心莲内酯对大鼠实验性心肌缺血的保护作用"", 《中医药研究》 * |
| 姜敏辉等: ""红景天对心肌缺血损伤保护作用的实验研究及临床应用"", 《江苏医药》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055513A (en) * | 2015-07-22 | 2015-11-18 | 中国中医科学院中药研究所 | Effect of Shenlian extract in preventing and treating myocardial ischemic diseases and haze caused myocardial ischemic diseases |
| CN113559208A (en) * | 2021-08-27 | 2021-10-29 | 浙江天真健康科技有限公司 | A Chinese medicinal composition for protecting cardiovascular and cerebrovascular diseases, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN101596230B (en) | Medicinal composition for treating hepatopathy | |
| CN103083582B (en) | Medicine for treating hyperlipidemia | |
| CN101708237B (en) | Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof | |
| CN104000871A (en) | Drug for treating myocardial ischemia | |
| CN104001026A (en) | Medicine for treating myocardial ischemia | |
| CN103239562B (en) | Traditional Kazak medicament composition for treating diabetes mellitus and preparation method of traditional Kazak medicament composition | |
| CN102908513A (en) | Application of traditional Chinese medicine composition in medicine for treating arrhythmia | |
| CN103120738A (en) | Medicinal composition for treating ischemic cerebral apoplexy | |
| CN102670893B (en) | Traditional Chinese medicine composition for treating atherosclerosis | |
| CN103385963B (en) | Chinese medicine preparation for treating angina pectoris caused by coronary heart disease | |
| CN105435196A (en) | Externally-applied traditional Chinese medicine ointment for treating qi stagnation and blood stasis coronary angina pectoris with chronic gastritis and preparation method thereof | |
| CN103989723A (en) | Drug for treating myocardial ischemia | |
| CN100540025C (en) | Treat Parkinsonian Chinese medicine preparation and preparation method thereof | |
| CN103989758A (en) | Pharmaceutical composition for relieving myocardial ischemia | |
| CN104042735A (en) | Medicament for alleviating myocardial ischemia | |
| CN104000884A (en) | Pharmaceutical composition for relieving myocardial ischemia | |
| CN104474015A (en) | Medicine for lowering blood pressure and blood fat and preparation method of medicine | |
| CN103127413B (en) | Pharmaceutical preparation for treating coronary diseases | |
| CN101612233B (en) | Chinese medicine preparation for detumescence and analgesia | |
| CN102172378A (en) | Traditional Chinese medicine for treating diabetic coronary heart disease | |
| CN101716271B (en) | Chinese traditional medicine effective fraction composite used for curing coronary heart disease and preparation method thereof | |
| CN102309561A (en) | Pharmaceutical composition used for preventing and treating urarthritis and hyperuricemia | |
| CN105213774A (en) | A kind of pharmaceutical composition for the treatment of chronic heart failure | |
| CN102716434B (en) | Medicine for oral use for treating hypotension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140827 |